Prime Health Zinc Citrate 50 mg Tablets
Prime Health Zinc Citrate 50 mg Tablets, NPN 80032541: natural health product licensed in Canada. Medicinal ingredients: Zinc.
If this product were sold in France
- Declared dose above a limit
Zinc: up to 50 mg a day according to the dosing instructions published by Health Canada (1 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 15 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- To check
Zinc: up to 50 mg a day according to the dosing instructions published by Health Canada, above the tolerable upper intake level from EFSAEuropean Food Safety Authority. for adults (25 mg a day). The EFSA reference covers total daily intake, from food and supplements.
limite supérieure de sécurité (UL). EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Zinc Source : Citrate de zinc | 50 mg | 50,000 µg |
Non-medicinal ingredients
Hydroxypropylméthylcellulose, Cellulose, Croscarmellose de sodium, Phosphate dicalcique, Stéarate de magnésium, Dioxyde de silicium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Comprimé | 1 Tous les jours |
Uses authorised in Canada
Helps to maintain healthy skin. Helps to maintain immune function. A factor in the maintenance of good health. Helps in connective tissue formation.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Known Adverse Reactions
Zinc supplementation can cause a copper deficiency.
Product record
- Other names
- Canda Zinc Citrate 50 mg Tablets, Maple Health Zinc Citrate 50 mg Tablets, Maple Leaf Zinc Citrate 50 mg Tablets, Vital Source Zinc Citrate 50 mg Tablets
- Licence holder
- Prime Health Ltd. (Canada Global Life Sciences)
- NPN or DIN-HM
- 80032541
- Status
- Active licence
- Licence date
- 31 May 2012
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Officinale
Source
Official Health Canada record, licence 80032541
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Prime Health Zinc Citrate 50 mg Tablets (Prime Health Ltd. (Canada Global Life Sciences)): composition and ingredients”, https://compoatlas.com/en/supplements/canada/80032541-prime-health-zinc-citrate-50-mg-tablets, updated 31 May 2012.